Subscribe to Newsletter

Retina

Business & Profession Business and Innovation

The Road to “OCT Anywhere”

| Sponsored by Heidelberg Engineering | 3 min read

Harness the power of imaging technologies that can help deepen diagnostic insights, transform surgery planning, and improve clinical workflow

Subspecialties Retina

Retinal Disease and False Hope

| Jon Greenaway

A new film investigates the doctors offering bogus cures for incurable retinal conditions

Subspecialties Retina

Retinal Disease and False Hope

| Jon Greenaway

A new film investigates the doctors offering bogus cures for incurable retinal conditions

Subspecialties Retina

TES: Reining in RP Progression

| Sponsored by Okuvision | 7 min read

Florian Gekeler and Okuvision CEO, Alfred Stett, discuss Okuvision’s role in developing OkuStim therapy for retinitis pigmentosa patients

Subspecialties Retina

Costs Down, Solve Rates Up

| Daan Panneman | 4 min read

A new cost-effective targeted sequencing panel may provide accessible and affordable genetic diagnoses for patients and clinicians the world over.

Subspecialties Retina

Wide Field, Deep Learning

| Pr. Eric Souied | 5 min read

How AI-assisted UWF imaging is being used to classify retinal vascular diseases

Subspecialties Retina

Eye Sp.Eye Innovation

| Jon Greenaway | 6 min read

How the Sp.Eye system makes intravitreal more efficient for doctors and safer and less stressful for patients

Subspecialties Retina

DR Snapshot

| Sarah Healey | 2 min read

Diabetic retinopathy poses a large global threat to patients and the economy

Subspecialties Retina

A Helping Hand

| Maria Znamenska | 2 min read

AI platform alleviates pressure of ophthalmologists

Subspecialties Retina

Weighing the Cost

| Oscelle Boye | 4 min read

Is Ozempic’s higher rates of diabetic retinopathy and adverse ocular events compared to other GLP-1 agonists cause for concern?

Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine

Register

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: